AR079354A1 - Amidas 5-amino-4-hidroxi-pentoil - Google Patents
Amidas 5-amino-4-hidroxi-pentoilInfo
- Publication number
- AR079354A1 AR079354A1 ARP100104571A ARP100104571A AR079354A1 AR 079354 A1 AR079354 A1 AR 079354A1 AR P100104571 A ARP100104571 A AR P100104571A AR P100104571 A ARP100104571 A AR P100104571A AR 079354 A1 AR079354 A1 AR 079354A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- formulas
- group
- pentoil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Inhibidores del VIH de la formula (1) en donde R1 es halo, alcoxi C1-4, trifluorometoxi; R2 es: grupo de formulas (2); R3 es grupo de formulas (3); R4 es: grupo de formulas (4); n es 0 o 1; A es CH o N; R5 y R6 son hidrogeno, alquilo C1-4, halo; R7 y R8 son alquilo C1-4 o alcoxi C1-4 alquilo C1-4; R9 es alquilo C1-4, ciclopropilo, trifluorometilo, alcoxi C1-4, o dimetilamino; R10 es hidrogeno, alquilo C1-4, ciclopropilo, trifluorometilo, alcoxi C1-4, o dimetilamino; sales de adicion farmacéuticamente aceptables y los solvatos de los mismos; composiciones farmacéuticas que contienen dichos compuestos como principio activo y procesos para preparar dichos compuestos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09178979 | 2009-12-11 | ||
EP10162370 | 2010-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR079354A1 true AR079354A1 (es) | 2012-01-18 |
Family
ID=43534084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100104571A AR079354A1 (es) | 2009-12-11 | 2010-12-10 | Amidas 5-amino-4-hidroxi-pentoil |
Country Status (24)
Country | Link |
---|---|
US (1) | US8592429B2 (es) |
EP (1) | EP2509950B1 (es) |
JP (1) | JP5797662B2 (es) |
KR (1) | KR101771698B1 (es) |
CN (1) | CN102770413B (es) |
AP (1) | AP3217A (es) |
AR (1) | AR079354A1 (es) |
AU (1) | AU2010329867B2 (es) |
BR (1) | BR112012013493B1 (es) |
CA (1) | CA2783929C (es) |
DK (1) | DK2509950T3 (es) |
EA (1) | EA020758B1 (es) |
ES (1) | ES2536774T3 (es) |
HK (1) | HK1177454A1 (es) |
IL (1) | IL219272A (es) |
JO (1) | JO3090B1 (es) |
MX (1) | MX2012006613A (es) |
NZ (1) | NZ599916A (es) |
PL (1) | PL2509950T3 (es) |
PT (1) | PT2509950E (es) |
SG (1) | SG181609A1 (es) |
TW (1) | TWI485149B (es) |
UY (1) | UY33098A (es) |
WO (1) | WO2011070131A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109963854B (zh) | 2017-03-16 | 2022-04-12 | 江苏恒瑞医药股份有限公司 | 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
EP0534511A1 (en) * | 1991-08-16 | 1993-03-31 | Merck & Co. Inc. | HIV protease inhibitors useful for the treatment of aids |
CN1089269A (zh) * | 1993-01-04 | 1994-07-13 | 希巴-盖吉股份公司 | 新颖的作为治疗剂的5-氨基-4-羟基己酸衍生物 |
US5733882A (en) * | 1994-01-17 | 1998-03-31 | Smithkline Beecham Corporation | Retroviral protease inhibitors |
PT708085E (pt) * | 1994-10-19 | 2002-11-29 | Novartis Ag | Eteres antivirais de isosteros de substrato de aspartato protease |
CN100369904C (zh) * | 2001-02-14 | 2008-02-20 | 泰博特克药品有限公司 | 2-(取代-氨基)-苯并噻唑磺酰胺hiv蛋白酶抑制剂 |
TWI286476B (en) * | 2001-12-12 | 2007-09-11 | Tibotec Pharm Ltd | Combination of cytochrome P450 dependent protease inhibitors |
US7834043B2 (en) * | 2003-12-11 | 2010-11-16 | Abbott Laboratories | HIV protease inhibiting compounds |
MX2007009655A (es) * | 2005-02-10 | 2007-09-26 | Medivir Ab | Inhibidores de la proteasa del vih. |
CN101115713A (zh) * | 2005-02-10 | 2008-01-30 | 美迪维尔公司 | 人类免疫缺陷性病毒蛋白酶抑制剂 |
WO2007048557A1 (en) * | 2005-10-25 | 2007-05-03 | Medivir Ab | Protease inhibitors |
JO2841B1 (en) * | 2006-06-23 | 2014-09-15 | تيبوتيك فارماسيوتيكالز ليمتد | 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV) |
US20090306112A1 (en) * | 2006-07-21 | 2009-12-10 | Gilead Sciences, Inc. | Antiviral protease inhibitors |
-
2010
- 2010-11-30 JO JOP/2010/0423A patent/JO3090B1/ar active
- 2010-12-10 SG SG2012042552A patent/SG181609A1/en unknown
- 2010-12-10 JP JP2012542555A patent/JP5797662B2/ja not_active Expired - Fee Related
- 2010-12-10 PL PL10790938T patent/PL2509950T3/pl unknown
- 2010-12-10 NZ NZ599916A patent/NZ599916A/xx unknown
- 2010-12-10 EP EP10790938.4A patent/EP2509950B1/en active Active
- 2010-12-10 TW TW099143139A patent/TWI485149B/zh active
- 2010-12-10 KR KR1020127017093A patent/KR101771698B1/ko active IP Right Grant
- 2010-12-10 MX MX2012006613A patent/MX2012006613A/es active IP Right Grant
- 2010-12-10 EA EA201290487A patent/EA020758B1/ru not_active IP Right Cessation
- 2010-12-10 CN CN201080055694.9A patent/CN102770413B/zh active Active
- 2010-12-10 WO PCT/EP2010/069328 patent/WO2011070131A1/en active Application Filing
- 2010-12-10 ES ES10790938.4T patent/ES2536774T3/es active Active
- 2010-12-10 UY UY0001033098A patent/UY33098A/es not_active Application Discontinuation
- 2010-12-10 US US13/515,187 patent/US8592429B2/en active Active
- 2010-12-10 BR BR112012013493-0A patent/BR112012013493B1/pt active IP Right Grant
- 2010-12-10 AU AU2010329867A patent/AU2010329867B2/en not_active Ceased
- 2010-12-10 DK DK10790938.4T patent/DK2509950T3/en active
- 2010-12-10 PT PT107909384T patent/PT2509950E/pt unknown
- 2010-12-10 CA CA2783929A patent/CA2783929C/en active Active
- 2010-12-10 AP AP2012006228A patent/AP3217A/xx active
- 2010-12-10 AR ARP100104571A patent/AR079354A1/es active IP Right Grant
-
2012
- 2012-04-19 IL IL219272A patent/IL219272A/en active IP Right Grant
-
2013
- 2013-04-10 HK HK13104373.4A patent/HK1177454A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6470846A2 (es) | Derivados aminobut´ricos sustituidos como inhibidores de neprilisina | |
CO6400220A2 (es) | Derivados de sulfonamida | |
CR20110592A (es) | Aril-piridinas como inhibidoras de sintasa de aldosterona | |
DOP2019000140A (es) | Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih | |
UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
AR076850A1 (es) | Derivados sustituidos de indazol y aza-indazol como moduladores de la gamma secretasa. | |
UY33075A (es) | Derivados de ciclohexano y usos de los mismos | |
MX2015010354A (es) | Derivados de acido betulinico modificados con aquilo c-3 y alquenilo utiles en el tratamiento de virus de inmunodeficiencia humana (vih). | |
AR089781A1 (es) | Fluorometil-5,6-dihidro-4h-[1,3]oxazinas | |
AR087915A1 (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1 | |
AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
CR10671A (es) | Compuestos azabiciclicos como inhibidores de la recaptacion de monoaminas | |
PH12014502285A1 (en) | Anti-malarial agents | |
ECSP088257A (es) | Derivados de amida | |
CO6341560A2 (es) | Proceso para la preparacion de derivados de pirimidina sustituidos. | |
PE20140629A1 (es) | Derivados de fenil-isoxazol y procedimiento para la preparacion de los mismos | |
AR072802A1 (es) | Derivados piperidinicos de esteres de acido bifenil-2-il-carbamico, antagonistas de receptores muscarinicos m3, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento de trastornos digestivos,respiratorios y/o urinarios. | |
DOP2014000283A (es) | Derivados de pirimidona como agentes antimalaricos | |
BR112012006233B8 (pt) | composto de fórmula i, composição farmacêutica e usos de um composto | |
AR079354A1 (es) | Amidas 5-amino-4-hidroxi-pentoil | |
ATE452636T1 (de) | 3-azabicycloä4.1.0üheptan-derivate zur behandlung von depressionen | |
AR093168A1 (es) | COMPUESTOS DE OXAZOLIDINONA COMO INHIBIDORES DEL CANAL KCa3.1 | |
MX2018003250A (es) | Moduladores no esteroideos del receptor de glucocorticoides para administración local de fármacos. | |
UA108744C2 (xx) | 5-аміно-4-гідроксипентоїламіди | |
TH130492B (th) | 5-อะมิโน-4-ไฮดรอกซีเพนโทอิลเอไมด์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |